Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 8, 2019
The role of the dermatologist in the immune-mediated/allergic diseases - position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum
A Balato, A Raimondo, P Arenberger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 6, 2021
Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices
A Herman, W Uter, T Rustemeyer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 2, 2020
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions
A Balato, F Ayala, M Bruze, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 14, 2020
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study
A Dattola, A Balato, M Megna, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 30, 2024
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis)
L Gargiulo, L Ibba, P Malagoli, et al.
The British Journal of Dermatology
|
December 23, 2018
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience
A Conti, F Peccerillo, P Amerio, et al.
Expert Opinion on Biological Therapy
|
December 18, 2023
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
A Chiricozzi, S M Ferrucci, L Di Nardo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)
L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 8, 2024
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study
L Gargiulo, L Ibba, F Piscazzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy
L Sacchelli, F Filippi, A Balato, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 8, 2019
The role of the dermatologist in the immune-mediated/allergic diseases - position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum
A Balato, A Raimondo, P Arenberger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 6, 2021
Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices
A Herman, W Uter, T Rustemeyer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 2, 2020
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions
A Balato, F Ayala, M Bruze, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 14, 2020
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study
A Dattola, A Balato, M Megna, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 30, 2024
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis)
L Gargiulo, L Ibba, P Malagoli, et al.
The British Journal of Dermatology
|
December 23, 2018
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience
A Conti, F Peccerillo, P Amerio, et al.
Expert Opinion on Biological Therapy
|
December 18, 2023
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
A Chiricozzi, S M Ferrucci, L Di Nardo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)
L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 8, 2024
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study
L Gargiulo, L Ibba, F Piscazzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy
L Sacchelli, F Filippi, A Balato, et al.
Page
of 6